Mechanisms of ADAMTS13 inhibition in iTTP

被引：0
|
作者：
Laemmle, Bernhard [1 ,2 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Univ Med Ctr Mainz, Mainz, Germany
来源：
BLOOD | 2023年 / 141卷 / 24期
关键词：
D O I：
10.1182/blood.2023020512
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Halkidis et al(1) present an article that is a must-read for all hematologists, not just those specializing in autoimmune thrombotic thrombocytopenic purpura (iTTP). Every researcher and clinician will benefit from studying this article because it highlights that a scientific topic, no matter how well studied, may benefit from critical reexamination, performance of additional studies, and adjusting the conclusions as indicated by this process.
引用
收藏
页码：2919 / 2920
页数：2
相关论文
共 50 条
  • [1] Relapse and iTTP: beyond the ADAMTS13 activity
    Cataland, Spero R.
    BLOOD, 2024, 143 (25) : 2567 - 2568
  • [2] Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP
    Saito, Kenki
    Sakai, Kazuya
    Kubo, Masayuki
    Azumi, Hidekazu
    Hamamura, Atsushi
    Ochi, Shinichi
    Amagase, Hiroki
    Kunieda, Hisako
    Ogawa, Yoshiyuki
    Yagi, Hideo
    Matsumoto, Masanori
    BLOOD ADVANCES, 2024, 8 (09) : 2151 - 2159
  • [3] Mechanisms of ADAMTS13 regulation
    DeYoung, Veronica
    Singh, Kanwal
    Kretz, Colin A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (12) : 2722 - 2732
  • [4] The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction
    Austin, S. K.
    Starke, R. D.
    Lawrie, A. S.
    Cohen, H.
    Machin, S. J.
    Mackie, I. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 536 - 544
  • [5] Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy
    Tanaka, Haruyuki
    Sakai, Kazuya
    Tamura, Shusuke
    Shiwaku, Hiroya
    Nakamura, Junko
    Ueda, Yasunori
    Bamba, Seiya
    Nishikubo, Masashi
    Nagai, Yuya
    Matsumoto, Masanori
    ANNALS OF HEMATOLOGY, 2025, : 1507 - 1514
  • [6] Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
    De Waele, Laure
    Curie, Alexandre
    Kangro, Kadri
    Tellier, Edwige
    Kaplanski, Gilles
    Mannik, Andres
    Tersteeg, Claudia
    Joly, Berangere S.
    Coppo, Paul
    Veyradier, Agnes
    De Meyer, Simon F.
    Roose, Elien
    Vanhoorelbeke, Karen
    BLOOD ADVANCES, 2021, 5 (21) : 4480 - 4484
  • [7] ADAMTS13 in nephrology [ADAMTS13 in der Nephrologie]
    Bockmeyer C.L.
    Modde F.
    Becker J.U.
    Der Nephrologe, 2013, 8 (1): : 69 - 70
  • [8] Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor:: in vitro inhibition of ADAMTS13 activity by hemoglobin
    Studt, JD
    Hovinga, JAK
    Antoine, G
    Hermann, M
    Rieger, M
    Scheiflinger, F
    Lämmle, B
    BLOOD, 2005, 105 (02) : 542 - 544
  • [9] Molecular mechanisms of hereditary ADAMTS13 deficiency.
    Schneppenheim, R
    Angerhaus, D
    Obser, T
    Scheiflinger, F
    Will, K
    Budde, U
    BLOOD, 2003, 102 (11) : 91A - 91A
  • [10] Endocytotic mechanisms contributing to the internalization of ADAMTS13 by macrophages
    Verbij, F. C.
    Sorvillo, N.
    Kaijen, P.
    Ten Brinke, A.
    Fijnheer, R.
    Voorberg, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 132 - 133
12345